U.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market
U.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market
RELEASE DATE
31-Dec-2008
31-Dec-2008
REGION
North America
North America
Research Code: N500-01-00-00-00
SKU: HC02102-NA-MR_07565
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02102-NA-MR_07565
Description
This research service explores the market for prescription ophthalmics used for the treatment of ocular diseases such as age-related macular degeneration (AMD), allergic conjunctivitis, chronic dry eye, cataract, and diabetic retinopathy in the United States of America. It analyzes the various challenges faced by pharmaceutical and biotech companies, and the competitive advantages and disadvantages of their products in the market.
Table of Contents
Executive Summary
- Overview
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Overview
- Introduction
- Disease Overview
Patient Forecasts
- Age-Related Macular Degeneration
- Allergic Conjunctivitis
- Chronic Dry Eye
- NSAIDs
- Diabetic Retinopathy
Market Trends
- Industry Challenges and Strategies
- Market Drivers
Approved Therapies and Treatment Trends
Pipeline Analysis
Introduction
Market Share and Revenue Forecasts
Decision Support Databases
Related Research
Popular Topics
This research service explores the market for prescription ophthalmics used for the treatment of ocular diseases such as age-related macular degeneration (AMD), allergic conjunctivitis, chronic dry eye, cataract, and diabetic retinopathy in the United States of America. It analyzes the various challenges faced by pharmaceutical and biotech companies, and the competitive advantages and disadvantages of their products in the market.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N500-01-00-00-00 |
Is Prebook | No |